Emergent Biosolutions Inc (EBS)

Total Costs & Expenses

$359.40M

Quarterly · Period ending: · USD

EBS logo

EBS Total Costs & Expenses

Latest reported$359.40M
EBS Quarterly Total Costs & Expenses ($395.80M → $359.40M)
High-resolution chart · PNG

EBS total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Emergent Biosolutions Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
359,400,000
145,600,000
165,300,000
154,300,000
140,400,000
173,600,000
204,200,000
229,300,000
458,200,000
260,600,000
320,400,000
512,600,000
630,800,000
311,900,000
385,500,000
285,200,000
315,700,000
301,100,000
445,800,000
363,700,000
383,000,000
247,600,000
324,900,000
323,900,000
268,700,000
204,100,000
258,500,000
241,100,000
250,200,000
217,800,000
259,500,000
152,300,000
153,400,000
127,300,000
140,744,000
101,665,000
92,243,000
101,948,000
100,734,000
107,436,000
93,282,999
81,807,000
94,638,000
95,219,000
66,017,000
91,943,000
103,355,000
106,922,000
102,463,000
79,342,000
74,814,000
70,897,000
67,706,000
56,433,000
70,345,999
56,791,000
61,726,000
53,249,000
61,958,000
57,354,000
67,934,000
54,039,000
68,284,000
53,381,000
47,327,000
43,622,000
49,679,000
47,223,000
50,481,000
47,253,000
34,896,000
41,261,000
40,927,000
31,545,000
46,479,000
39,222,000
31,843,000
32,279,000
42,990,000
23,746,000
0
0
-82,777,000
0
0
0
-70,542,000
0
0
0
395,800,000
466,900,000
630,800,000
381,400,000
395,800,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.